0 454

Cited 0 times in

The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck

Authors
 Gwi Eon Kim  ;  Woo-Ick Yang  ;  Sang-wook Lee  ;  Yong Bae Kim  ;  Chang Ok Suh  ;  Joo-Heon Yoon  ;  Young Taik Oh  ;  Hyun Cheol Chung  ;  Byung Soo Kim 
Citation
 CANCER, Vol.91(12) : 2343-2352, 2001 
Journal Title
CANCER
ISSN
 0008-543X 
Issue Date
2001
MeSH
Adult ; Aged ; Biomarkers/analysis* ; CD56 Antigen/analysis ; Female ; Granzymes ; Head and Neck Neoplasms/enzymology* ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Humans ; Immunohistochemistry ; Killer Cells, Natural/immunology ; Lymphoma/enzymology* ; Lymphoma/mortality ; Lymphoma/pathology ; Male ; Middle Aged ; Serine Endopeptidases/analysis* ; Survival Rate ; T-Lymphocytes, Cytotoxic/immunology ; Treatment Outcome
Keywords
angiocentric lymphoma ; natural killer/T-cell lymphoma ; granzyme B ; immunohistochemical study
Abstract
BACKGROUND:
The objectives of this study were to establish a correlation between granzyme B expression and the clinicopathologic characteristics of patients with angiocentric lymphomas of the head and neck and to determine whether the expression of granzyme B had any influence on the treatment outcomes of such patients.
METHODS:
Fifty-seven patients with angiocentric lymphoma of the head and neck who were treated between 1987 and 1996 were divided into two groups according to whether their tumors were immunoreactive for granzyme B: the granzyme B negative group (n = 22 patients) and the granzyme B positive group (n = 35 patients). The clinicopathologic features, immunohistochemical findings, patterns of disease failure, and survival data for the granzyme B positive group were compared with those for the granzyme B negative group.
RESULTS:
Greater than 60% of patients with angiocentric lymphoma of the head and neck were shown to have granzyme B positive tumors. All tumors that expressed granzyme B also consistently coexpressed CD56, indicating that they probably are the neoplastic equivalent of either natural killer (NK) cells or activated cytotoxic T cells. Although there were no significant differences in histopathologic features or expression of CD45RO and polyclonal CD3-epsilon between the groups, the Epstein-Barr virus genomes were detected more frequently in the granzyme B positive group compared with the granzyme B negative group. Despite a similar rate of complete remission after initial treatment, the locoregional recurrence rate of patients in the granzyme B positive group was much higher compared with patients in the granzyme B negative group. In addition, compared with patients in the granzyme B negative group, patients in the granzyme B positive group also had an increased risk of systemic disease recurrence and a decreased overall survival rate.
CONCLUSIONS:
The data indicate that the cytotoxic granule-associated protein, granzyme B, may be used as an additional marker for identifying NK/T-cell lymphoma and as a prognostic indicator for risk assessment in patients with angiocentric lymphoma of the head and neck.
Full Text
http://onlinelibrary.wiley.com/doi/10.1002/1097-0142(20010615)91:12%3C2343::AID-CNCR1267%3E3.0.CO;2-3/abstract
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Otorhinolaryngology (이비인후과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
Yonsei Authors
Kim, Gwi Eon(김귀언)
Yoon, Joo Heon(윤주헌)
Chung, Hyun Cheol(정현철) ORCID logo https://orcid.org/0000-0002-0920-9471
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/142846
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links